U.S. markets closed
  • S&P 500

    4,128.80
    +31.63 (+0.77%)
     
  • Dow 30

    33,800.60
    +297.03 (+0.89%)
     
  • Nasdaq

    13,900.19
    +70.88 (+0.51%)
     
  • Russell 2000

    2,243.47
    +0.88 (+0.04%)
     
  • Crude Oil

    59.34
    -0.26 (-0.44%)
     
  • Gold

    1,744.10
    -14.10 (-0.80%)
     
  • Silver

    25.33
    -0.26 (-1.02%)
     
  • EUR/USD

    1.1905
    -0.0016 (-0.13%)
     
  • 10-Yr Bond

    1.6660
    +0.0340 (+2.08%)
     
  • GBP/USD

    1.3707
    -0.0028 (-0.20%)
     
  • USD/JPY

    109.6300
    +0.3660 (+0.33%)
     
  • BTC-USD

    59,727.81
    -740.43 (-1.22%)
     
  • CMC Crypto 200

    1,235.89
    +8.34 (+0.68%)
     
  • FTSE 100

    6,915.75
    -26.47 (-0.38%)
     
  • Nikkei 225

    29,768.06
    +59.08 (+0.20%)
     

Edwards Lifesciences's Earnings: A Preview

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

On Wednesday, January 27, Edwards Lifesciences (NYSE:EW) will release its latest earnings report. Here is Benzinga's outlook for the company.

What Are Earnings, Net Income, And Earnings Per Share?

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Wall Street analysts see Edwards Lifesciences reporting earnings of $0.53 per share on revenue of $1.19 billion. In the same quarter last year, Edwards Lifesciences reported earnings per share of $1.46 on revenue of $1.17 billion.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

Wall Street analysts who study this company will publish analyst estimates of revenue and EPS. The averages of all analyst EPS and revenue estimates are called the "consensus estimates"; these consensus estimates can have a significant effect on a company's performance during an earnings release. When a company posts earnings or revenue above or below a consensus estimate, it has posted an "earnings surprise", which can really move a stock depending on the difference between actual and estimated values.

View more earnings on EW

If the company were to report earnings in line when it publishes results Wednesday, quarterly profit would be down 63.7%. Sales would be up 1.36% on a year-over-year basis. Here is how the company's reported EPS has stacked up against analyst estimates in the past:

EPS Estimate

0.44

0.17

1.33

1.48

EPS Actual

0.51

0.34

1.51

1.46

Revenue Estimate

1.08 B

789.42 M

1.08 B

1.14 B

Revenue Actual

1.14 B

925.00 M

1.13 B

1.17 B

Stock Performance

Over the last 52-week period, shares of Edwards Lifesciences are up 11.18%.

Do not be surprised to see the stock move on comments made during its conference call. Edwards Lifesciences is scheduled to hold the call at 17:00:00 ET and can be accessed here.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.